Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

Jun 29 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

FDA Safety Initiatives Could Suffer Under Trump's Budget Proposal

May 24 2017

Orphan Designation Requests To Get Slower Reviews

May 11 2016

Gilead Buys Its Third Priority Review Voucher, But Is The Mania Over?

Feb 22 2017

US FDA 'Medical Innovation Development Plan' Outlined By Gottlieb

Jun 21 2017

FDA's Budget Flat In House Bill, But Path For 'Cures' Funding Cleared

Jun 29 2017

Additional Topics

United States Rare Diseases Drug Review Review Pathway FDA Regulation BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.